Vascudyne
PrivateLast Round
Grant
Jun 1, 2025
Total Funding Raised
$14M
Company Overview
Vascudyne is a biotechnology company that develops a bioengineered tissue platform designed to create implantable blood vessels and heart valves for cardiovascular care.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vascudyne Comparables
Compare Vascudyne with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Xeltis | 87% | |
| Anova Biomedical | 81% | |
| VeriGraft | 81% |
Vascudyne Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 1, 2025 | ||||
| Series A | Dec 2, 2021 |
Key People
Founding team and executive leadership
Vascudyne Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Congressionally Directed Medical Research Programs | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2025
Monthly visitors increased 83% MoM.
- Jun 1, 2025
$4M grant received from Congressionally Directed Medical Research Programs.
Vascudyne Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Vascudyne's valuation, stock price, and market status.
Is Vascudyne a public or private company?
Vascudyne is a private company.
What is the current stock price of Vascudyne?
Vascudyne is a private company with no public stock price. No recent secondary market data is available.
How much is Vascudyne worth (valuation)?
Valuation information for Vascudyne is not publicly available.
Can I buy Vascudyne stock?
Vascudyne shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Vascudyne's last funding round?
Vascudyne's most recent funding round was Grant on June 1, 2025.
Who are the main investors in Vascudyne?
Key investors in Vascudyne include Congressionally Directed Medical Research Programs.
Will Vascudyne IPO soon?
No public IPO plans have been announced for Vascudyne.
How can I track Vascudyne secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Vascudyne's secondary market activity and sign up for updates.